Features of hormonal homeostasis in women with climacteric syndrome associated with endometriosis

In: Reproductive Endocrinology · 2018 · vol. 0(42) , pp. 34–38 · doi:10.18370/2309-4117.2018.42.34-38 · W2897653253
article OA: diamond CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

Women with climacteric syndrome and endometriosis showed higher gonadotropic hormones and cortisol alongside lower sex steroids, indicating early ovarian exhaustion and potential hypercortisolemia contributing to symptoms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

This study examined hormonal homeostasis in 170 women with endometriosis (106 with climacteric manifestations and 64 without), compared with 153 women without endometriosis (83 with climacteric manifestations and 70 healthy controls), assessing sex steroids (estradiol, progesterone, testosterone), gonadotropins (FSH, LH), and also prolactin, cortisol, and CA-125. The authors found that, compared with climacteric syndrome without endometriosis, women with endometriosis and climacteric syndrome had a significantly higher incidence of elevated gonadotropins (FSH, LH) and cortisol alongside lower sex steroid concentrations, supporting “asthenization” and reduced ovarian reserve in this group. They also reported that climacteric disorders in these women develop on a background of relative hyperestrogenemia, with hypercortisolemia proposed as an additional mechanism beyond estrogen deficiency, and they frame menopause as a stress factor affecting adaptive mechanisms. The paper is centrally about endometriosis — it evaluates hormonal homeostasis in climacteric syndrome among women with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The aim of the study was searching of endocrine homeostasis in patients with climacteric changes against the backdrop of endometriosis and establishing the correlative relationships between the severity of menopausal symptoms and hormonal changes.170 women with endometriosis were examined (of which 106 patients with endometriosis and climacteric manifestations – Group I, 64 with endometriosis without climacteric manifestations – Group II) and 153 women without endometriosis (of which 83 women with climacteric manifestations – Group III and 70 healthy women in the control Group IV). Women of all groups under study were divided into subgroups, depending on the age and phase of the menopause, and the concentration of sex steroid (estradiol, progesterone, testosterone) and gonadotropic (FSH and LH) hormones was investigated in the examined groups of patients prolactin, cortisol and cancer marker CA-125.As a result of the studies, installed the incidence of gonadotropic hormones (FSH, LH) and cortisol in the context of lowering the concentrations of sex steroid hormones compared with patients with climacteric syndrome (CS) without endometriosis was significantly higher in patients with CS in the context of endometriosis, which confirms the expressed asthenization in this contingent of women and early exhaustion they have an ovarian reserve. In this case, climacteric disorders develop in such women against the background of relative hyperestrogenemia, which indicates the involvement of other mechanisms for the development of CS in this category of women, in addition to estrogen deficiency, in particular hypercortisolemia.Therefore, summing up the above can be assumed that premenopause and climax, even physiological, are a stress factor for the woman’s body, which, along with the burdened comorbid state, causes significant stresses in the adaptive mechanisms and the launch of a stress-relieving system as a pathogenetic link in the development of moderate and severe forms of climacteric syndrome.
Full text 4,929 characters · extracted from oa-doi-fallback · click to expand
Features of hormonal homeostasis in women with climacteric syndrome associated with endometriosis DOI: https://doi.org/10.18370/2309-4117.2018.42.34-38Keywords: climacteric syndrome, endometriosis, endocrine homeostasisAbstract The aim of the study was searching of endocrine homeostasis in patients with climacteric changes against the backdrop of endometriosis and establishing the correlative relationships between the severity of menopausal symptoms and hormonal changes. 170 women with endometriosis were examined (of which 106 patients with endometriosis and climacteric manifestations – Group I, 64 with endometriosis without climacteric manifestations – Group II) and 153 women without endometriosis (of which 83 women with climacteric manifestations – Group III and 70 healthy women in the control Group IV). Women of all groups under study were divided into subgroups, depending on the age and phase of the menopause, and the concentration of sex steroid (estradiol, progesterone, testosterone) and gonadotropic (FSH and LH) hormones was investigated in the examined groups of patients prolactin, cortisol and cancer marker CA-125. As a result of the studies, installed the incidence of gonadotropic hormones (FSH, LH) and cortisol in the context of lowering the concentrations of sex steroid hormones compared with patients with climacteric syndrome (CS) without endometriosis was significantly higher in patients with CS in the context of endometriosis, which confirms the expressed asthenization in this contingent of women and early exhaustion they have an ovarian reserve. In this case, climacteric disorders develop in such women against the background of relative hyperestrogenemia, which indicates the involvement of other mechanisms for the development of CS in this category of women, in addition to estrogen deficiency, in particular hypercortisolemia. Therefore, summing up the above can be assumed that premenopause and climax, even physiological, are a stress factor for the woman’s body, which, along with the burdened comorbid state, causes significant stresses in the adaptive mechanisms and the launch of a stress-relieving system as a pathogenetic link in the development of moderate and severe forms of climacteric syndrome. References - Vovk, I.B., Khominska, Z.B., Zakharenko, N.F., et al. “Characteristics of hormonal status in women with endometriosis.” Woman Health 10.56 (2010): 162–4. - Zakharenko, N.F. “Clinical and anamnestic characteristics of women with different forms of endometriosis.” Pediatrics, Obstetrics and Gynecology: Sci. Pract. Journal 72.5 (2010): 97–104. - Ilovaiskaya, I.A. “Termination of menstrual function in the reproductive age and premature aging.” Gynecology endocrinology 1.102 (2015): 52–4. - Levkovich, M.A., Ermolova, N.V., Avanesova, T.G., Markaryan, I.V. “Modern views on the pathogenesis of genital endometriosis: the role of hormonal, immunological, genetic factors.” Tavrian med.-biol. Bulletin 20.2–2 (2017): 185–9. - Tatarchuk, Т.F., Zakharenko, N.F., Manoliak, I.P., et al. “Features of the manifestation of climacteric syndrome in women with endometriosis and possible ways of its correction.” Science Journal of the MOH of Ukraine 2 (2014): 71–7. - Tatarchuk, Т.F., Yefimenko, O.A., Tutchenko, T.N. “Stress and Involution of the Female Reproductive System.” Reproductive health of woman 5.34 (2007): 153–6. - Yureneva, S.V., Ermakova, E.I. “Menopausal disorders in women: pathogenesis, clinic, diagnosis, treatment, prevention.” MedicaMente 3.2 (2017): 32–8. - Inceboz, U. “Endometrios is after menopause womens.” Health (Lond) 11.5 (2015): 711–5. - Gemmell, L.C., Webster, K.E., Kirtley, S., et al. “The management of menopause in women with endometriosis: a systematic review.” Human Reproduction Update 23.4 (2017): 481–500. - DeZambotti, M., Trinder, J., Colrain, I.M., Baker, F.C. “Menstrual cycle – related variation in autonomic nervous system functioning in women in the early menopausal transition with and without in somnia disorder.” Psychoneuroendocrinology 75 (2017): 44–51. Downloads Published How to Cite Issue Section License Copyright (c) 2018 Н. Ф. Захаренко, Н. В. Коваленко, І. М. Ретунська This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK